B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Neu5ac2en

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Neu5ac2en, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Zanamivir
2 shared targets · score 50.7
Loading evidence profile...

This evidence profile for Neu5ac2en is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.